Explore the latest FDA-approved therapies for non-small cell lung cancer, focusing on EGFR mutations and treatment strategies in oncology.
Alia Lynch, PharmD, BCOP
Advertisement
Articles by Alia Lynch, PharmD, BCOP
Navigating FDA-Approved EGFR-Targeted Therapies in NSCLC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Ferric Maltol to Adolescents, Addressing a Critical Gap in Iron Deficiency Care
2
Occupational Factors Can Increase Risk of Long COVID
3
T-DXd Granted Breakthrough Therapy Designation in Post-Neoadjuvant HER2-Positive Early Breast Cancer
4
Reading Between the Codes: How Seemingly Unrelated Conditions May Signal Earlier Multiple Myeloma
5